0001790340-24-000008.txt : 20240209
0001790340-24-000008.hdr.sgml : 20240209
20240209161246
ACCESSION NUMBER: 0001790340-24-000008
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240208
FILED AS OF DATE: 20240209
DATE AS OF CHANGE: 20240209
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hall Brett Matthew
CENTRAL INDEX KEY: 0001870437
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40675
FILM NUMBER: 24615038
MAIL ADDRESS:
STREET 1: C/O IMMUNEERING CORPORATION
STREET 2: 245 MAIN STREET, SECOND FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Immuneering Corp
CENTRAL INDEX KEY: 0001790340
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 245 MAIN STREET, SECOND FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-500-8080
MAIL ADDRESS:
STREET 1: 245 MAIN STREET, SECOND FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
wk-form4_1707513136.xml
FORM 4
X0508
4
2024-02-08
0
0001790340
Immuneering Corp
IMRX
0001870437
Hall Brett Matthew
245 MAIN STREET
SECOND FLOOR
CAMBRIDGE
MA
02142
0
1
0
0
CHIEF SCIENTIFIC OFFICER
0
Stock Option
6.09
2024-02-08
4
A
0
130900
0
A
2034-02-08
Class A Common Stock
130900
130900
D
The option vests and becomes exercisable in equal monthly installments over a four-year period commencing on February 1, 2024, and will be fully vested and exercisable on January 1, 2028.
/s/ Michael D. Bookman, Attorney-in-Fact for Brett M. Hall
2024-02-09